BioRestorative Therapies (BRTX) Net Cash Flow (2010 - 2025)
BioRestorative Therapies (BRTX) reported Net Cash Flow of $923,917 for Q4 2025, compared with -$941,554 a year earlier.
Analysis
BioRestorative Therapies (BRTX) Net Cash Flow (2010 - 2025) Analysis & Trends
For FY2025, BioRestorative Therapies posted Net Cash Flow of $952,261.
- Net Cash Flow has a five-year compound annual growth rate of -20.8% (FY2020 to FY2025).
- By year, Net Cash Flow came in at -$336,487 in FY2024, -$829,395 in FY2023, -$19.31 million in FY2022 and $17.96 million in FY2021 (+486.4%).
- The Q4 2025 figure ranks as the highest quarterly Net Cash Flow since Q2 2024.
- Per Business Quant data, the three quarters before Q4 2025 came in at -$951,670 (Q3 2025), $320,329 (Q2 2025) and $659,685 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 1.62 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 652.90 Mn |
| 10 | BioRestorative Therapies | 1.03 Mn | -22.90 Mn | 17,964.00 | 923,917.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 923,917.00 |
| Sep 30, 2025 | -951,670.00 |
| Jun 30, 2025 | 320,329.00 |
| Mar 31, 2025 | 659,685.00 |
| Dec 31, 2024 | -941,554.00 |
| Sep 30, 2024 | -762,803.00 |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 272,703.00 |
| Dec 31, 2023 | -1.59 Mn |
| Sep 30, 2023 | 653,223.00 |
| Jun 30, 2023 | -464,524.00 |
| Mar 31, 2023 | 159,892.00 |
| Dec 31, 2022 | -4.86 Mn |
| Sep 30, 2022 | -11.36 Mn |
| Jun 30, 2022 | -1.39 Mn |
| Mar 31, 2022 | -1.70 Mn |
| Dec 31, 2021 | 19.93 Mn |
| Sep 30, 2021 | -629,364.00 |
| Jun 30, 2021 | -741,829.00 |
| Mar 31, 2021 | -563,701.00 |
API Access
BioRestorative Therapies Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=BRTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();